Cited by 312Metabolism and Genetic DisordersAmino Acid Enzymes and MetabolismGlycogen Storage Diseases and Myoclonus

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

Grompe, Markus, Lindstedt, Sven, Al-Dhalimy, Muhsen, Kennaway, Nancy G., Papaconstantinou, John, Torres-Ramos, Carlos A., Ou, Ching-Nau, Finegold, Milton·1995·Nature Genetics

DOI 10.1038/ng0895-453

Open this paper in CoChat — free account

Abstract

Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice homozygous for a FAH gene disruption have a neonatal lethal phenotype caused by liver dysfunction and do not represent an adequate model of the human disease. Here we demonstrate that treatment of affected animals with 2-(2-nitro-4-trifluoro-methylbenzyol)-1,3-cyclohexanedione abolished neonatal lethality, corrected liver function and partially normalized the altered expression pattern of hepatic mRNAs. The prolonged lifespan of affected animals resulted in a phenotype analogous to human tyrosinaemia type I including hepatocellular carcinoma. The adult FAH-/- mouse will serve as useful model for studies of the pathophysiology and treatment of hereditary tyrosinaemia type I as well as hepatic cancer.

Integrity signals

Registry

Crossref · 10.1038/ng0895-453

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,341
Methods of Enzymatic Analysis
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078
[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction
Mullis, K. B., & Faloona, F. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)55023-6 · Cited by 5,762
Methods of enzymatic analysis
(1985) · International Journal of Biochemistry · doi:10.1016/0020-711x(85)90098-9 · Cited by 3,494
Current Protocols in Molecular Biology
Teplitz, R. L. (1989) · JAMA · doi:10.1001/jama.1989.03420090114049 · Cited by 1,848
Chromatographic and Electrophoretic Techniques
(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.170-c · Cited by 1,646
CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.Preprint
Ron, D., & Habener, J. F. (1992) · Genes & Development · doi:10.1101/gad.6.3.439 · Cited by 1,156

Show all 50 references

Research works printed but not linked: 3

Mitchell, G.A., Lambert, M. & Tanguay, P.M. in The metabolic and molecular basis of inherited disease, (eds Scriver, C.R., Beaudet, A.L, Sly, W. & Valte, D.) 1077–1106 (MacGraw-Hill, New York, 1994).
Smith, I. in Chromatography and electrophoretic techniques, (ed. Smith, I.) 104–121 (John Wiley & Sons, New York, 1969).
Sturman, J.A. & Applegarth, D.A. in Neuromethods. (eds Boulton, A.A., Baker, G.B. & Wood, J.D.) (Humana Press Inc., Clifton, 1985).

Sorted by citations

Items 101–200 of 312

Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition
Taylor, A. M., Preston, A. J., Paulk, N. K., Sutherland, H., Keenan, C. M., Wilson, P. J. M., Wlodarski, B., Grompe, M., Ranganath, L. R., Gallagher, J. A., et al. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.04.013 · Cited by 49
Self-citation
HCV animal models and liver disease
Vercauteren, K., de Jong, Y. P., & Meuleman, P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.013 · Cited by 48
Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells
Endo, F., & Sun, M. (2002) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1015646400182 · Cited by 49
A universal system to select gene-modified hepatocytes in vivo
Nygaard, S. C., Barzel, A., Haft, A., Major, A. M., Finegold, M. J., Kay, M. A., & Grompe, M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8166 · Cited by 47
Self-citation
Animal Models to Study Hepatitis C Virus Infection
Burm, R., Collignon, L., Mesalam, A. A., & Meuleman, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01032 · Cited by 47
Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice
Wang, H., Dolezal, J. M., Kulkarni, S., Lu, J. L., Mandel, J. A., Jackson, L. E., Alencastro, F., Duncan, A. W., & Prochownik, E. V. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004099 · Cited by 46
Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage†
Buitrago‐Molina, L. E., Pothiraju, D., Lamlé, J., Marhenke, S., Kossatz-Boehlert, U., Breuhahn, K., Manns, M. P., Malek, N. P., & Vogel, A. (2009) · Hepatology · doi:10.1002/hep.23014 · Cited by 44
Liver-directed gene therapy: Promises, problems and prospects at the turn of the century
Ghosh, S. S., Takahashi, M., Thummala, N. R., Parashar, B., Chowdhury, N. R., & Chowdhury, J. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80429-8 · Cited by 44
Progress toward cell‐directed therapy for phenylketonuria
Harding, C. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01027.x · Cited by 43
Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice
Chen, Y., Chen, L., Wu, X., Zhao, Y., Wang, Y., Jiang, D., Liu, X., Zhou, T., Li, S., Wei, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37247-9 · Cited by 43
Renal Tubular Dysgenesis in Twin-Twin Transfusion Syndrome
Oberg, K. C., Pestaner, J. P., Bielamowicz, L., & Hawkins, E. P. (1999) · Pediatric and Developmental Pathology · doi:10.1007/s100249900086 · Cited by 43
Genetically modified animals in pharmacological research: future trends
Rudolph, U., & Möhler, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00195-8 · Cited by 43
Genetic and metabolic liver disease
Thompson, R. J., Portmann, B. C., & Roberts, E. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00004-0 · Cited by 43
Hepatitis C virus infection and related liver disease: the quest for the best animal model
Mailly, L., Robinet, É., Meuleman, P., Baumert, T. F., & Zeisel, M. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00212 · Cited by 45
Animal Models of Tyrosinemia
Nakamura, K., Tanaka, Y., Mitsubuchi, H., & Endo, F. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1556s · Cited by 42
CRISPR/Cas9: at the cutting edge of hepatology
Pankowicz, F. P., Jarrett, K. E., Lagor, W. R., & Bissig, K. (2017) · Gut · doi:10.1136/gutjnl-2016-313565 · Cited by 43
A Mouse Model of Renal Tubular Injury of Tyrosinemia Type 1
SUN, M.-S., Hattori, S., Kubo, S., Awata, H., Matsuda, I., & Endo, F. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v112291 · Cited by 40
Fah Knockout Animals as Models for Therapeutic Liver Repopulation
Grompe, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_20 · Cited by 42
Self-citation
Humanized Mice Are Instrumental to the Study of Plasmodium falciparum Infection
Tyagi, R. K., Tandel, N., Deshpande, R., Engelman, R. W., Patel, S. D., & Tyagi, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02550 · Cited by 42
Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1
VanLith, C. J., Guthman, R. M., Nicolas, C. T., Allen, K. L., Du, Z., Joo, D. J., Nyberg, S. L., Lillegard, J. B., & Hickey, R. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.252 · Cited by 39
Abnormal lipid processing but normal long-term repopulation potential of myc−/− hepatocytes
Edmunds, L. R., Otero, P. A., Sharma, L., D'Souza, S. S., Dolezal, J. M., David, S., Lu, J. L., Lamm, L., Basantani, M. K., Zhang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8856 · Cited by 37
The extent of liver injury determines hepatocyte fate toward senescence or cancer
Wang, C., Chen, W., Wu, Y., You, P., Zheng, S., Liu, C.-C., Xiang, D., Wang, M., Cai, Y., Zhao, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0622-x · Cited by 40
Activation of nuclear factor E2‐related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development†
Marhenke, S., Lamlé, J., Buitrago‐Molina, L. E., Cañón, J. M. F., Geffers, R., Finegold, M. J., Sporn, M. B., Yamamoto, M. P., Manns, M. P., Grompe, M., et al. (2008) · Hepatology · doi:10.1002/hep.22391 · Cited by 37
Self-citation
IL6 supports long-term expansion of hepatocytes in vitro
Guo, R., Jiang, M., Wang, G., Li, B., Jia, X., Ai, Y., Chen, S., Tang, P., Liu, A., Yuan, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35167-8 · Cited by 36
Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I
Prieto‐Álamo, M., & Laval, F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12614 · Cited by 36
Extensive changes in liver gene expression induced by Hereditary Tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC)
Luijerink, M., Jacobs, S. M. M., van Beurden, E. A. C. M., Koornneef, L. P., Klomp, L. W. J., Berger, R., & van den Berg, I. E. T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00433-1 · Cited by 36
In Vivo Selection of Hepatocytes Transduced with Adeno-Associated Viral Vectors
Chen, S. J., Tazelaar, J., Moscioni, A. D., & Wilson, J. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0065 · Cited by 35
Kidney repair and stem cells: a complex and controversial process
Yeagy, B. A., & Cherqui, S. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1789-x · Cited by 35
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
Kabbani, M., Michailidis, E., Steensels, S., Fulmer, C. G., Luna, J. M., Pen, J. L., Tardelli, M., Razooky, B. S., Ricardo-Lax, I., Zou, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111321 · Cited by 38
Self-citation
AAV-Mediated Gene Targeting Is Significantly Enhanced by Transient Inhibition of Nonhomologous End Joining or the Proteasome In Vivo
Paulk, N. K., Loza, L. I. M., Finegold, M. J., & Grompe, M. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.038 · Cited by 35
Self-citation
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model
Orejuela, D., Jorquera, R., Bergeron, A., Finegold, M. J., & Tanguay, R. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.014 · Cited by 34
Self-citation
Therapeutic Liver Reconstitution With Murine Cells Isolated Long After Death
Erker, L., Azuma, H., Lee, A. Y., Guo, C., Orloff, S., Eaton, L., Benedetti, E., Jensen, B., Finegold, M., Willenbring, H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.082 · Cited by 34
Self-citation
Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts
Kim, J., Kim, K.-P., Lim, K., Lee, S. C., Yoon, J., Song, G., Hwang, S. I., Schöler, H. R., Cantz, T., & Han, D. (2015) · Scientific Reports · doi:10.1038/srep15706 · Cited by 34
Liver tumors in children with metabolic disorders.
Schady, D. A., Roy, A., & Finegold, M. J. (2015) · PubMed Central · doi:10.3978/j.issn.2224-4336.2015.10.08 · Cited by 33
Self-citation
Normal and Neoplastic Growth Suppression by the Extended Myc Network
Wang, H., & Prochownik, E. (2022) · Cells · doi:10.3390/cells11040747 · Cited by 31
Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse
Lock, E. A., Gaskin, P., Ellis, M. K., Provan, W. M., Robinson, M., & Smith, L. L. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00205-x · Cited by 33
Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I
Zhang, L., Shao, Y., Li, L., Tian, F., Cen, J., Chen, X., Hu, D. M., Zhou, Y., Xie, W., Zheng, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31460 · Cited by 34
Physiological variations of stem cell factor and stromal‐derived factor‐1 in murine models of liver injury and regeneration
Swenson, E. S., Kuwahara, R., Krause, D. S., & Theise, N. D. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01659.x · Cited by 32
Engraftment of Bone Marrow-Derived Epithelial Cells
Arnam, J. S. V., Herzog, E. L., Grove, J. E., Bruscia, E. M., Ziegler, E. C., Swenson, S. E., & Krause, D. S. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:1:021 · Cited by 32
Sustained Phosphorylation of Bid Is a Marker for Resistance to Fas-Induced Apoptosis During Chronic Liver Diseases
Vogel, A., Aslan, J. E., Willenbring, H., Klein, C., Finegold, M. J., Mount, H. T. J., Thomas, G., & Grompe, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.012 · Cited by 32
Self-citation
Bioengineering considerations in liver regenerative medicine
Ogoke, O., Oluwole, J., & Parashurama, N. (2017) · Journal of Biological Engineering · doi:10.1186/s13036-017-0081-4 · Cited by 31
Cell therapy for liver disorders: past, present and future
Ortuño‐Costela, M. D. C., Pinzani, M., & Vallier, L. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01050-2 · Cited by 34
Animal models for the study of human hepatitis B and D virus infection: New insights and progress
Burwitz, B. J., Zhou, Z., & Li, W. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104898 · Cited by 34
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury
Wilkinson, P. D., & Duncan, A. W. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1719175 · Cited by 31
Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes
Fontes, P., Komori, J., López, R., Marsh, W. J., & Lagasse, E. (2020) · Liver Transplantation · doi:10.1002/lt.25872 · Cited by 28
Nitisinone: a review
Zeybek, A. Ç. A., & Zübarioğlu, T. (2017) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s92995 · Cited by 28
Infection and Inflammation: Impacts on Oncogenesis
Dittmar, T., Zaenker, K. S., & Schmidt, A. (2006) · Contributions to microbiology · doi:10.1159/isbn.978-3-318-01310-8 · Cited by 28
A Mouse Model of Inducible Liver Injury Caused by Tet-On Regulated Urokinase for Studies of Hepatocyte Transplantation
Song, X., Guo, Y., Duo, S., Che, J., Wu, C., Ochiya, T., Ding, M., & Deng, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090349 · Cited by 27
Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress
Dieter, M. Z., Freshwater, S. L., Miller, M. L., Shertzer, H. G., Dalton, T. P., & Nebert, D. W. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00273-9 · Cited by 27
Animal models in the study of hepatitis C virus-associated liver pathologies
Lerat, H., Higgs, M. R., & Pawlotsky, J. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.14 · Cited by 29
Updates in Hepatitis E virus (HEV) field; lessons learned from human liver chimeric mice
Sayed, I. M., & Meuleman, P. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2086 · Cited by 27
Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents
Rittelmeyer, I., Rothe, M., Brugman, M. H., Iken, M., Schambach, A., Manns, M. P., Baum, C., Modlich, U., & Ott, M. (2012) · Hepatology · doi:10.1002/hep.26204 · Cited by 27
mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma
Buitrago‐Molina, L. E., & Vogel, A. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988011 · Cited by 26
Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric Mice
Zou, C., Vercauteren, K., Michailidis, E., Kabbani, M., Zoluthkin, I., Quirk, C., Chiriboga, L. A., Yazicioglu, M. N., Anguela, X. M., Meuleman, P., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.033 · Cited by 26
Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver
Ren, J., Yu, D., Wang, J., Xu, K., Xu, Y., Sun, R., An, P., Li, C., Feng, G., Zhang, Y., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00760-3 · Cited by 26
Therapeutic liver repopulation for phenylketonuria
Harding, C. O., & Gibson, K. M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9099-1 · Cited by 26
Liver Stem Cells: the Fall and Rise of Tissue Biology
Theise, N. D. (2003) · Hepatology · doi:10.1002/hep.1840380405 · Cited by 26
Hepatocytes break the rules of senescence in serial transplantation studies. Is there a limit to their replicative capacity?
Fausto, N. (1997) · Europe PMC (PubMed Central) · Cited by 25
PEDIATRIC HEPATOLOGY
Balistreri, W. F. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70103-3 · Cited by 25
Carcinogenesis Driven by Bone Marrow-Derived Stem Cells
Dittmar, T., Seidel, J., Zaenker, K. S., & Niggemann, B. (2006) · KARGER eBooks · doi:10.1159/000092971 · Cited by 25
Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1
Zhang, Q., Tiyaboonchai, A., Nygaard, S. C., Baradar, K., Major, A. M., Balaji, N., & Grompe, M. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.042 · Cited by 24
Self-citation
Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
Zhang, X., Wang, X., Wu, M., Ghildyal, R., & Yuan, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.715450 · Cited by 28
Stem Cells: An Overview
Denham, M., Conley, B. J., Olsson, F., Cole, T. J., & Mollard, R. (2005) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb2301s28 · Cited by 30
A Fungal Perspective on Human Inborn Errors of Metabolism: Alkaptonuria and Beyond
Peñalva, M. A. (2001) · Fungal Genetics and Biology · doi:10.1006/fgbi.2001.1284 · Cited by 24
Round two for liver gene therapy
Wilson, J. M. (1996) · Nature Genetics · doi:10.1038/ng0396-232 · Cited by 24
Generation of Functional Hepatic Cells from Pluripotent Stem Cells
Han, S. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s10-008 · Cited by 26
Brief Report: Parthenogenetic Embryonic Stem Cells are an Effective Cell Source for Therapeutic Liver Repopulation
Espejel, S., Eckardt, S., Harbell, J. W., Roll, G. R., McLaughlin, K. J., & Willenbring, H. (2014) · Stem Cells · doi:10.1002/stem.1726 · Cited by 23
Liver stem cells: Plasticity of the liver epithelium
Tsuchiya, A., & Lu, W. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i9.1037 · Cited by 26
Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9
Kieckhaefer, J. E., Maina, F., Wells, R. G., & Wangensteen, K. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1678725 · Cited by 22
Establishment of Humanized Mice for the Study of HBV
Lai, F., Wee, C. Y. Y., & Chen, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638447 · Cited by 23
Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing
Pankowicz, F. P., Barzi, M., Kim, K. H., Legras, X. D., Martins, C. S., Wooton‐Kee, C. R., Lagor, W. R., Marini, J. C., Elsea, S. H., Bissig-Choisat, B., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.037 · Cited by 22
Noninvasive 3‐dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene
Hickey, R., Mao, S. A., Amiot, B. P., Suksanpaisan, L., Miller, A. C., Nace, R. A., Glorioso, J. M., O’Connor, M. K., Peng, K. W., Ikeda, Y., et al. (2014) · Liver Transplantation · doi:10.1002/lt.24057 · Cited by 21
Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1
Tanguay, R. M., Angileri, F., & Vogel, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_4 · Cited by 21
Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays
Zhu, M., Li, L., Lu, T., Yoo, H., Zhu, J., Gopal, P., Wang, S. C., Porembka, M. R., Rich, N. E., Kagan, S., et al. (2020) · Hepatology · doi:10.1002/hep.31096 · Cited by 21
Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
Wang, H., Lu, J. L., Alencastro, F., Roberts, A., Fiedor, J., Carroll, P. A., Eisenman, R. N., Ranganathan, S., Torbenson, M. S., Duncan, A. W., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.018 · Cited by 18
Stem Cells in Liver Regeneration and Their Potential Clinical Applications
Drosos, I., & Kolios, G. C. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9437-4 · Cited by 22
Mechanisms of Liver Injury Relevant to Pediatric Hepatology
Tanner, M. S. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795439 · Cited by 20
In vitro and in vivo translational models for rare liver diseases
Haugabook, S. J., Ferrer, M., & Ottinger, E. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.029 · Cited by 21
Stem Cells as a Treatment for Chronic Liver Disease and Diabetes
Levičar, N., Dimarakis, I., Flores, C., Tracey, J., Gordon, M. Y., & Habib, N. A. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_11 · Cited by 20
Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network
Prochownik, E. V. (2022) · Cells · doi:10.3390/cells11243974 · Cited by 17
Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
Li, L., Zhang, Q., Yang, H., Zou, Q., Lai, C., Jiang, F., Zhao, P., Luo, Z., Yang, J., Chen, Q., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764787 · Cited by 19
Animal Modeling of Pediatric Liver Cancer
Whitlock, R. S., Yang, T., Vasudevan, S. A., & Woodfield, S. E. (2020) · Cancers · doi:10.3390/cancers12020273 · Cited by 20
Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokinetics
Bateman, R. L., Ashworth, J. R., Witte, J. F., Baker, L., Bhanumoorthy, P., Timm, D. E., Hurley, T. D., Grompe, M., & McClard, R. W. (2007) · Biochemical Journal · doi:10.1042/bj20060961 · Cited by 19
Self-citation
A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?
Yoshizato, K., & Tateno, C. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.826649 · Cited by 19
Animal Models Reveal Pathophysiologies of Tyrosinemias
Endo, F., Tanaka, Y., Tomoeda, K., Tanoue, A., Tsujimoto, G., & Nakamura, K. (2003) · Journal of Nutrition · doi:10.1093/jn/133.6.2063s · Cited by 19
Bone Marrow-Derived Hepatocytes
Mitchell, C., & Fausto, N. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64188-0 · Cited by 19
Who needs a liver transplant? (new disease specific indications)
Baker, A. J., Dhawan, A. K., & Heaton, N. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.5.460 · Cited by 18
METABOLIC LIVER DISEASE IN THE PEDIATRIC PATIENT
Kelly, D. A., & McKiernan, P. J. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70361-5 · Cited by 18
Molecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1
Angileri, F., Roy, V., Morrow, G., Scoazec, J., Gadot, N., Orejuela, D., & Tanguay, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.002 · Cited by 17
In Vivo Selection of Transplanted Hepatocytes by Pharmacological Inhibition of Fumarylacetoacetate Hydrolase in Wild-type Mice
Paulk, N. K., Wursthorn, K., Haft, A., Pelz, C., Clarke, G. N., Newell, A. H., Olson, S. B., Harding, C. O., Finegold, M. J., Bateman, R. L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.154 · Cited by 17
Self-citation
Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study
Ding, K., Wu, S., Ying, W., Pan, Q., Li, X., Zhao, D., Li, X., Zhao, Q., Zhu, Y., Ren, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17564 · Cited by 17
Kidneys of Mice With Hereditary Tyrosinemia Type I Are Extremely Sensitive to Cytotoxicity
Jacobs, S. M. M., van Beurden, D., Klomp, L. W. J., Berger, R., & van den Berg, I. E. T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000198810.57642.b4 · Cited by 16
Clinical translation of liver regeneration therapies: A conceptual road map
Greenbaum, L. E., Ukomadu, C., & Tchorz, J. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113847 · Cited by 17
Hepatocyte Nuclear Factor-1 as Marker of Epithelial Phenotype Reveals Marrow-Derived Hepatocytes, but Not Duct Cells, After Liver Injury in Mice
Swenson, E. S., Guest, I., Ilic, Z., Mazzeo-Helgevold, M., Lizardi, P., Hardiman, C. A., Sell, S., & Krause, D. S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0148 · Cited by 17
Relationships Between Regeneration, Wound Healing, and Cancer
Maggiore, G., & Zhu, H. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-123558 · Cited by 18
Hepatic Neoplasia and Metabolic Diseases in Children
Roy, A., & Finegold, M. J. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.07.002 · Cited by 16
Self-citation
Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation
Xiang, D., Liu, C.-C., Wang, M.-J., Li, J., Chen, F., Yao, H., Yu, B., Lu, L., Borjigin, U., Chen, Y., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.230 · Cited by 16
Peripheral blood as a source of stem cells for regenerative medicine
Romagnani, P., Lasagni, L., & Romagnani, S. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.193 · Cited by 16
“Adult” Stem Cells: Tissue Specific or Not?
Verfaillie, C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50092-4 · Cited by 16
Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice
Stone, D., Takeuchi, R., Dulin, H., Loprieno, M. A., Strongin, D. E., Sathees, S., Cradick, T. J., Aubert, M., Roychoudhury, P., Gordon, J., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101470 · Cited by 15

Authors: Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kennaway, N. G., Papaconstantinou, J., Torres-Ramos, C. A., Ou, C.-N., & Finegold, M.
Affiliations: Oregon Health & Science University (US)
Sahlgrenska University Hospital (SE)
The University of Texas Medical Branch at Galveston (US)
Texas Children's Hospital (US)
ORCID: Grompe, Markus
Finegold, Milton
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1995-08
Volume: 10
Issue: 4
Pages: 453-460
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0895-453
OpenAlex: W2073223227
Semantic Scholar: 475d9ce000d032d0d790441f5db803f2c24584d3
Cited by: 312
References: 50
Citations by year: 2026: 5 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 16 · 2019: 9 · 2018: 10 · 2017: 17 · 2016: 11 · 2015: 16 · 2014: 11 · 2013: 11 · 2012: 16
FWCI: 5.26
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R01DK048252, DK48252-02)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords: fumarylacetoacetate hydrolase, neonatal lethality, liver dysfunction, pharmacotherapy, hepatocellular carcinoma, hepatic gene expression, disease models
MeSH terms: alpha-Fetoproteins, Amino Acid Metabolism, Inborn Errors, Amino Acids, Animals, Cyclohexanones, Disease Models, Animal, Enzyme Inhibitors, Female, Heptanoates, Humans, Hydrolases, Liver, Liver Diseases, Liver Neoplasms, Male, Mice, Inbred C57BL, Nitrobenzoates, Pancreas, RNA, Messenger, Tyrosine, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks